Tomasz Rzymski
Krakow, MA 30394, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Romaciclib, a CDK8/CDK19 inhibitor, can overcome venetoclax resistance through a combinatorial strategy.
Journal: bioRxiv : the preprint server for biology
Published: December 25, 2025
Integrated transcriptomic and functional modeling reveals AKT and mTOR synergy in colorectal cancer.
Integrated transcriptomic and functional modeling reveals AKT and mTOR synergy in colorectal cancer.
Journal: Scientific reports
Published: March 11, 2025
Transcriptional Regulation of Protein Synthesis by Mediator Kinase Represents a Therapeutic Vulnerability in MYC-driven Medulloblastoma.
Journal: Research square
Published: November 22, 2024
Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medulloblastoma.
Journal: Nature communications
Published: October 24, 2024
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Journal: The Journal of clinical investigation
Published: May 01, 2024
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.
Journal: The Journal of clinical investigation
Published: April 15, 2024
Transcriptional Regulation of Protein Synthesis by Mediator Kinase in MYC-driven Medulloblastoma.
Journal: bioRxiv : the preprint server for biology
Published: April 01, 2024
Selective Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibition by the SCH772984 Compound Attenuates In Vitro and In Vivo Inflammatory Responses and Prolongs Survival in Murine Sepsis Models.
Journal: International journal of molecular sciences
Published: August 17, 2021
Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulation.
Journal: Drug development research
Published: November 10, 2020
Discovery of indazole-pyridinone derivatives as a novel class of potent and selective MNK1/2 kinase inhibitors that protecting against endotoxin-induced septic shock.
Journal: European journal of medicinal chemistry
Published: September 11, 2020
Last Updated: 09/26/2026